x

Posted 26 January, 2023

RESMED INC appointed new CEO

CEO Change detected for ticker NYSE:RMD in a 8-K filed on 26 January, 2023.


  On January 25, 2023, our board of directors appointed Michael J. "Mick" Farrell as chair of our board of directors. Mick Farrell is our chief executive officer and a current director.  

Don't how to trade CEO change? Read Reasons for CEO Turnover and Effect on Stock Performance.
Overview of RESMED INC
Health Care/Life Sciences • Medical Equipment/Supplies
ResMed, Inc. engages in providing digital health and cloud-connected medical devices. Its digital health technologies and cloud-connected medical devices transform care for people with sleep apnea, chronic obstructive pulmonary disease, or COPD, and other chronic diseases. The firm operates through the Sleep and Respiratory Care and Software as a Service segments. The Sleep and Respiratory Care segment engages in the sleep and respiratory disorders sector of the medical device industry. The Software as a Service segment provides business management software as a service to out-of-hospital health providers. The company was founded by Peter C. Farrell in June 1989 and is headquartered in San Diego, CA.
Market Cap
$26.6B
View Company Details
RESMED INC by TradingView
Relevant filing section
Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. 

On January 25, 2023, our board of directors appointed Michael J. "Mick" Farrell as chair of our board of directors. Mick Farrell is our chief executive officer and a current director. The appointment was effective immediately. 

Dr. Peter C. Farrell, our founder, who has served as chair of the board of directors since the company was founded in 1989, will continue as a director and as a non-officer employee of ResMed. In recognition of Dr. Farrell's long and valuable service as chair, the board of directors appointed him to the new director position of chair emeritus, effective immediately. 

Ron Taylor will continue to serve as our lead director. 

There are no compensation changes in connection with any of these appointments. 

On January 26, 2023, we issued the press release furnished as Exhibit 99.2. The press release announces the board position changes described above.